膀胱癌的流行病学、筛查与预防
该专家协作综述基于国际癌症研究机构GLOBOCAN数据库2020年185国数据及近5年PubMed/MEDLINE文献,描述膀胱癌发病率、患病率与死亡率,并评估筛查与预防证据。膀胱癌为全球第十常见癌症,2020年有573 278例;男性发病率约为女性四倍;吸烟约占病例50%。无充分证据推荐常规筛查,高危人群靶向筛查可能降低死亡率但应作为前瞻性随机试验重点;戒烟是最重要预防干预。
要点
- 膀胱癌为全球第十常见癌症,2020年有573 278例,男性发病率约为女性四倍。
- 吸烟是主要风险因素,约占膀胱癌病例的50%。
- 无充分证据推荐常规膀胱癌筛查,高危个体靶向筛查可能降低死亡率。
核心结论
- 膀胱癌带来显著疾病负担,了解其流行病学与风险因素为疾病预防和患者诊疗提供基础。
研究设计与样本
- 专家协作综述,采用国际癌症研究机构GLOBOCAN数据库2020年185国膀胱癌估计发病与死亡数据,并通过PubMed/MEDLINE检索近5年英文文献以识别风险因素及当代筛查与预防证据。
主要发现
- 膀胱癌为全球第十常见癌症,2020年有573 278例。
- 膀胱癌男性发病率约为女性的四倍。
- 吸烟仍是主要风险因素,约占膀胱癌病例的50%。
- 无充分证据推荐常规膀胱癌筛查;高危个体(按吸烟史或职业暴露定义)靶向筛查可能降低膀胱癌死亡率,并应作为前瞻性随机试验的重点。
- 预防方面,戒烟是最重要干预,其次是减少职业与环境致癌物暴露。
临床怎么用
- 戒烟是降低膀胱癌病例和死亡的最重要行动。
- 无充分证据推荐常规膀胱癌筛查;高危个体(按吸烟史或职业暴露定义)靶向筛查可能降低膀胱癌死亡率,并应作为前瞻性随机试验的重点。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Bladder cancer (BC) represents a significant health problem due to the potential morbidity and mortality associated with disease burden, which has remained largely unaltered over time. OBJECTIVE: To provide an expert collaborative review and describe the incidence, prevalence, and mortality of BC and to evaluate current evidence for BC screening and prevention. EVIDENCE ACQUISITION: Data on the estimated incidence and mortality of BC for 2020 in 185 countries were derived from the International Agency for Research on Cancer GLOBOCAN database. A review of English-language articles published over the past 5 yr was conducted using PubMed/MEDLINE to identify risk factors in addition to contemporary evidence on BC screening and prevention. EVIDENCE SYNTHESIS: BC is the tenth most common cancer worldwide, with 573 278 cases in 2020. BC incidence is approximately fourfold higher in men than women. Tobacco smoking remains the principal risk factor, accounting for approximately 50% of cases. There is insufficient evidence to recommend routine BC screening. However, targeted screening of high-risk individuals (defined according to smoking history or occupational exposure) may reduce BC mortality and should be the focus of prospective randomized trials. In terms of disease prevention, smoking cessation represents the most important intervention, followed by a reduction in exposure to occupational and environmental carcinogens. CONCLUSIONS: BC confers a significant disease burden. An understanding of BC epidemiology and risk factors provides an optimal foundation for disease prevention and the care of affected patients. PATIENT SUMMARY: Bladder cancer is the tenth most common cancer worldwide and is approximately four times more common among men than among women. The main risk factors are tobacco smoking, followed by exposure to carcinogens in the workplace or the environment. Routine screening is not currently recommended, but may be beneficial in individuals at high risk, such as heavy smokers. Primary prevention is extremely important, and smoking cessation represents the most important action for reducing bladder cancer cases and deaths.
引用
- Lobo N, Afferi L, Moschini M, et al. Epidemiology, Screening, and Prevention of Bladder Cancer. Eur Urol Oncol. 2022. PMID: 36333236. doi:10.1016/j.euo.2022.10.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。